Medical Fair Asia 2026 will feature various companies that are redefining diagnosis, therapy, and care in the healthcare industry. From stroke diagnostics to collagen scaffolds, these exhibitors are turning research into tools clinicians can use. The event will showcase innovations advancing healthcare across the continuum of care.
One of the exhibitors is NEAR Brain, a medical AI startup from the Republic of Korea. The company is developing non-invasive hemodynamic analysis solutions for cerebrovascular diseases. Its flagship platform, Dr. NEAR flow, transforms MRI images into quantitative blood flow analysis, providing clinicians with objective insights into pressure, velocity, and flow for diagnosis and treatment planning.
Nunaps Inc., another company from the Republic of Korea, is dedicated to advancing clinically evidence-based solutions for neurological disorders. The company’s flagship product, Vividbrain, is a digital therapeutic to restore visual field defects caused by stroke. Nunaps is also developing multiple digital therapeutics targeting neurological conditions, including language disorders, cognitive impairment, and intermittent exotropia.
VSI Co., Ltd., an emerging company in Korea, specializes in manufacturing X-ray sources and commercializing X-ray generators using CNT technology. The company’s portable X-ray solutions are trusted by healthcare professionals and industry experts worldwide for their reliability, safety, and mobility.
ACRO Biomedical Co., Ltd. from Taiwan is dedicated to the research, development, and manufacturing of natural collagen-based scaffolds for advanced medical applications. The company’s proprietary supercritical CO2 decellularisation technology develops non-recombinant collagen scaffolds without the use of chemical cross-linking agents. These biocompatible scaffolds support effective tissue repair and regeneration, offering innovative solutions for a wide range of medical and regenerative medicine applications.
AIDOT Co., Ltd., a specialized medical AI company from the Republic of Korea, supports early disease prediction and more accurate clinical decision-making through AI-powered healthcare solutions. The company develops practical, clinically applicable solutions designed for real-world healthcare settings, helping improve both healthcare accessibility and diagnostic consistency.
Many of the exhibitors at Medical Fair Asia 2026 are actively seeking to expand globally through FDA clearance, clinical validation, and strategic partnerships. NEAR Brain has obtained medical device regulatory approval in Korea and is collaborating with leading institutions to expand its reach worldwide. They are working to drive the development of new medical technologies and improve patient outcomes.
As the healthcare industry continues to evolve, events like Medical Fair Asia 2026 provide a platform for companies to showcase their innovations and connect with potential partners and customers. By working together, they can help drive the development of new medical technologies and improve patient outcomes.
The innovations on display at Medical Fair Asia 2026 will have a significant impact on the lives of people affected by various medical conditions. For instance, Nunaps‘ digital therapeutics can help restore visual field defects caused by stroke, while ACRO Biomedical‘s collagen scaffolds can support effective tissue repair and regeneration. This is especially important for smart hospital growth in Asia.
With its diverse range of exhibitors and innovative solutions, Medical Fair Asia 2026 is an event not to be missed for anyone interested in the latest developments in the healthcare industry. It offers opportunities for companies to improve their hospital efficiency and showcase their latest products.
Medical Fair Asia 2026 is a significant event.